| | Isolates in extrapancreatic infections | Proportions from the total extrapancreatic infections presented in the 28 affected patients with AP
|
| | Bacteremia | | | Staphylococcus spp., (%) | 9 (64.2) | | Candida spp., (%) | 3 (21.4) | | Escherichia coli, (%) | 2 (14.2) | | Enterococcus spp., (%) | 2 (14.2) | | Stenotrophomonas maltophilia, (%) | 1 (7.1) | | Trichosporon beigelii, (%) | 1 (7.1) | | Urinary tract infections | | | Candida spp., (%) | 9 (64.2) | | Enterococcus spp., (%) | 6 (42.8) | | Staphylococcus spp., (%) | 1 (7.1) | | Acinetobacter calcoaceticus, (%) | 1 (7.1) | | Mycobacterium bovis, (%) | 1 (7.1) | | Pneumonia | | | Pseudomonas aeruginosa, (%) | 6 (50) | | Stenotrophomonas maltophilia, (%) | 4 (33.3) | | Staphylococcus spp., (%) | 3 (25) | | Enterococcus spp., (%) | 3 (25) | | Escherichia coli, (%) | 1 (8.3%) | | Acinetobacter calcoaceticus, (%) | 1 (8.3%) | | Achromobacter xylosoxidans, (%) | 1 (8.3%) | | Candida spp., (%) | 1 (8.3%) | | Cryptococcus neoformans, (%) | 1 (8.3%) | | Catheter-related infections | | | Staphylococcus spp., (%) | 1 (50) | | Pseudomonas aeruginosa, (%) | 1 (50) | | Candida spp., (%) | 1 (50) | | Other | | | Enterococcus spp., (%) | 6 (50) | | Escherichia coli, (%) | 4 (33.3) | | Staphylococcus spp., (%) | 2 (16.6) | | Pseudomonas aeruginosa, (%) | 2 (16.6) | | Candida spp., (%) | 2 (16.6) | | Klebsiella pneumoniae, (%) | 1 (8.3) | | Pseudomonas oryzihabitans, (%) | 1 (8.3) | | Clostridium difficile, (%) | 1 (8.3) | | Citrobacter freundii, (%) | 1 (8.3) | | Trichosporon beigelii, (%) | 1 (8.3) | | Entamoeba histolytica, (%) | 1 (8.3) |
|
|
